Profile
Peter Morsing served as the Chief Executive Officer of Wntresearch AB from 2017 to 2020.
Prior to that, he worked as the Director of Search & Evaluation at AstraZeneca LP.
He also served as the Global Head of Business Development & Strategy at Vaccinogen, Inc. in 2015.
Before his industry experience, he was an Associate Professor at the University of Lund and the University of North Carolina at Charlotte.
He later became a Professor at the University of Gothenburg.
Dr. Morsing earned a doctorate degree from the University of Lund.
Former positions of Peter Morsing
Companies | Position | End |
---|---|---|
WNTRESEARCH AB | Chief Executive Officer | 2020-10-14 |
University of Lund | Corporate Officer/Principal | - |
The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
University of Gothenburg | Corporate Officer/Principal | - |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Corporate Officer/Principal | - |
Training of Peter Morsing
University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
WNTRESEARCH AB | Health Technology |
Private companies | 2 |
---|---|
Vaccinogen, Inc.
Vaccinogen, Inc. BiotechnologyHealth Technology Vaccinogen, Inc. is a biotechnology company, which engages in the development and commercialization of vaccines and immunotherapeutic products for the battle of cancer. The company was founded by Michael G. Hanna, Jr. and Andrew L. Tussing on May 2, 2007 and is headquartered in Baltimore, MD. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Peter Morsing